Godavari Drugs has informed that a meeting of the Board of Directors of the Company will be held on May 30, 2013, to consider and approve the Audited Annual Financial results of the Company for the year ended March 31, 2013, and consider recommendation of dividend, if any along with the results of the quarter ended on March 31, 2013.
The above information is a part of company’s filings submitted to BSE.